Bank Of America Corp Phathom Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.17 Trillion
Q4 2024

A detailed history of Bank Of America Corp transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 166,505 shares of PHAT stock, worth $959,068. This represents 0.0% of its overall portfolio holdings.

Number of Shares

166,505

Previous 103,779 60.44%

Holding current value

$959,068

Previous $1.88 Million 27.93%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.45 - $18.94 $467,308 - $1.19 Million	62,726 Added 60.44%	166,505 $1.35 Million
Q3 2024 Nov 14, 2024	BUY	$10.25 - $19.5 $58,906 - $112,066	5,747 Added 5.86%	103,779 $1.88 Million
Q2 2024 Aug 14, 2024	SELL	$8.97 - $12.05 $70,172 - $94,267	-7,823 Reduced 7.39%	98,032 $1.01 Million
Q1 2024 May 15, 2024	BUY	$6.21 - $11.05 $149,425 - $265,885	24,062 Added 29.42%	105,855 $1.12 Million
Q4 2023 Feb 14, 2024	BUY	$6.99 - $10.71 $179,719 - $275,364	25,711 Added 45.85%	81,793 $746,000
Q2 2023 Aug 14, 2023	SELL	$7.28 - $14.32 $1.44 Million - $2.83 Million	-197,403 Reduced 77.88%	56,082 $803,000
Q1 2023 May 12, 2023	BUY	$6.19 - $12.36 $1.16 Million - $2.32 Million	188,023 Added 287.22%	253,485 $1.81 Million
Q4 2022 Feb 10, 2023	SELL	$9.18 - $11.53 $48,525 - $60,947	-5,286 Reduced 7.47%	65,462 $734,000
Q3 2022 Nov 14, 2022	SELL	$6.46 - $12.11 $134,342 - $251,839	-20,796 Reduced 22.72%	70,748 $784,000
Q2 2022 Aug 12, 2022	BUY	$6.2 - $15.5 $154,280 - $385,702	24,884 Added 37.33%	91,544 $772,000
Q1 2022 May 16, 2022	SELL	$11.55 - $20.06 $89,293 - $155,083	-7,731 Reduced 10.39%	66,660 $908,000
Q4 2021 Feb 08, 2022	BUY	$17.83 - $33.15 $175,750 - $326,759	9,857 Added 15.27%	74,391 $1.46 Million
Q3 2021 Nov 15, 2021	BUY	$30.69 - $36.83 $30,383 - $36,461	990 Added 1.56%	64,534 $2.07 Million
Q2 2021 Sep 13, 2021	BUY	$32.66 - $39.87 $2.08 Million - $2.53 Million	63,544 New	63,544 $2.15 Million

Others Institutions Holding PHAT

# of Institutions

158

Shares Held

68.6M

Call Options Held

52.3K

Put Options Held

635K

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $226M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Phathom Pharmaceuticals, Inc. Transaction History